RPL3 and colonic neoplasm: Moreover, it has been demonstrated that the reduction of uL3 expression levels is associated to drug-resistance phenotype in colon cancer cells; thus, we can speculate that the activation of UPR in absence of uL3 could contribute to sustain this phenotype [33].